Treatment
Treatment clinical trials
We’re tracking 8,556 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT05195697Recruiting
Study of outcomes for adults needing urgent surgery
This study looks at what factors affect outcomes for adults admitted for urgent (acute) surgical care at Skåne University Hospital. It may help the hospital improve care and understand which patients are at higher or lower risk.
Malmö, Skåne CountyAges 18 years+ - NCT05514730Recruiting
Treatment program for harmful sexual behaviors in children
This trial offers a treatment program for preteen children whose caregiver reports concerning sexual behaviors. It aims to help reduce these behaviors and improve child well-being, with participation guided by language and caregiver involvement.
Harrisburg, PennsylvaniaAges 4–12 - NCT04050644RecruitingPhase 4
Tested preservative-free vs standard eye drops after cataract surgery
This study compares different anti-inflammatory and pain-relief eye drops after cataract surgery to see which one works better. It focuses on whether preservative-free drops cause fewer problems (like irritation) while still protecting the eye during healing.
Leuven, Vlaams-BrabantAges 60 years+ - NCT05591651RecruitingPhase 4
Hyaluronic acid for sore, damaged breastfeeding nipples
This trial tests whether hyaluronic acid helps heal damaged nipple skin in breastfeeding mothers. It may help reduce pain and improve healing so breastfeeding can continue more comfortably.
OsijekAges Any age - NCT06221722Recruiting
Brain scan study for treating constipation
This trial uses brain scans to see if doctors can predict how well constipation treatments will work. It is for adults with functional constipation, but only if they have no other digestive problems or medical implants.
Yinchuan, NingxiaAges 18–45 - NCT06723990Recruiting
HER2 breast cancer treatment decision study
This study tests a tool called HER2DX to help doctors choose the best treatment for early stage HER2 positive breast cancer. It may help tailor therapy before or after surgery.
Milan, ItalyAges 18 years+ - NCT07089862Recruiting
Indobufen vs aspirin for unruptured brain aneurysm treatment
This trial compares two anti-clotting drugs—indobufen and aspirin—to see which works better for people getting a stent or flow diverter for an unruptured brain aneurysm. The goal is to find which drug causes fewer bleeding or clotting problems.
Beijing, Beijing MunicipalityAges 18–75 - NCT06456528RecruitingPhase 2/Phase 3
Study of QL0911 for low platelets caused by chemo
This trial tests a new drug called QL0911 to help raise platelet counts in people with cancer whose chemo has caused low platelets. The goal is to see if it can prevent delays in treatment.
HarbinAges 18–75 - NCT05964569RecruitingPhase 2
Personalized planning for proton radiation in low-grade brain tumors
This Phase 2 study tests a personalized, computer-guided way to plan proton beam radiation for adults with low-grade glioma. The goal is to see if the approach is feasible and can improve how treatment is planned.
HeidelbergAges 18 years+ - NCT05969080Recruiting
Therapy program to support recovery after self-harm
This study looks at a treatment and recovery approach for veterans who have had recent non-suicidal self-injury. It may help by testing ways to reduce self-harm urges and support safer recovery over time.
Durham, North CarolinaAges 18 years+ - NCT05305794RecruitingPhase 3
Weekly Ozempic for insulin-dependent double diabetes
This trial tests whether a weekly injection called Ozempic (a GLP-1 medicine) can improve blood sugar control in adults who have type 1 diabetes plus higher-risk features for type 2 diabetes. If you qualify, the study will compare Ozempic against standard care to see if it helps your diabetes outcomes.
DijonAges 18 years+ - NCT05681767Recruiting
Lifestyle coaching to support depression care in primary clinics
This trial studies whether motivational, multi-part lifestyle coaching can help adults with depression when they start treatment through a regular primary care clinic. If you’re eligible, the program may add supportive skills to help improve mood alongside usual care.
KuopioAges 18 years+ - NCT06830018Recruiting
New megestrol for advanced stomach or colon cancer with fatigue
This study tests a new form of megestrol (a medicine that can boost appetite and energy) for people with advanced stomach or colorectal cancer who also have fatigue and poor appetite. It is given as a first treatment, meaning you haven't had chemotherapy yet for your advanced cancer.
Shenyang, LiaoningAges 18–75 - NCT06898983RecruitingPhase 2
Romiplostim for low platelets from leukemia treatment
This trial tests a drug called Romiplostim to help raise low platelet counts caused by leukemia treatment. It is for adults with leukemia whose platelets are below 50 and who may benefit from this therapy.
Hefei, AnhuiAges 18–75 - NCT06843356Recruiting
Endovascular treatment for worsening mild stroke with basilar artery blockage
This trial tests a procedure to open a blocked artery in the back of the brain (basilar artery) for people who had a mild stroke that later got worse. If you are eligible, you may receive this treatment up to 24 hours after your symptoms worsen.
Wuhu, AnhuiAges 18 years+ - NCT06494384Recruiting
Problem-solving treatment in community health centers
This trial tests if training therapists in a specific counseling method (problem-solving treatment) helps patients with depression. It's for adults who have depression and are seen at certain community health centers.
Portland, OregonAges 18 years+ - NCT07481773Recruiting
Blood test to guide antibiotic decisions in the ICU
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
Montreal, QuebecAges 18 years+ - NCT07185438Recruiting
MRI-guided brain stimulation for teenage depression
This study tests whether a type of brain stimulation called rTMS, guided by an MRI scan, can safely help ease depression symptoms in teenagers. You would continue your regular medication during the study.
ChongqingAges 12–18 - NCT07527741Recruiting
HER2-Positive Breast Cancer Treatment Patterns Study
This study tracks how patients with HER2-positive early-stage breast cancer receive treatment and stick to their treatment plan after their care moves to local hospitals. The trial helps doctors understand whether patients follow through with their recommended therapy when treated closer to home.
Loznica, Bolnička 65Ages 18 years+ - NCT07106632RecruitingPhase 3
Genomic test to guide chemotherapy in young women with breast cancer
This trial uses a genomic test called Prosigna to help decide whether young women with hormone-sensitive breast cancer need chemotherapy after surgery. It aims to avoid unnecessary chemotherapy in those who can safely skip it.
BrusselsAges 35–45 - NCT07569198RecruitingPhase 2
Ketamine plus therapy for depression with suicidal thoughts
This study tests whether ketamine (a medication) combined with a specific type of therapy called DBT can help people with treatment-resistant depression and borderline personality disorder who are having thoughts of suicide. You would receive ketamine infusions alongside structured therapy sessions over 6 months.
Toronto, OntarioAges 18–70 - NCT03945305Recruiting
Remote ischemic conditioning for high blood pressure
This trial tests if a simple, non-invasive treatment called remote ischemic conditioning (briefly restricting blood flow to an arm) can safely lower blood pressure in people with essential hypertension. It is for adults aged 30-75 whose blood pressure is consistently high despite standard care.
Changchun, JilinAges 30–75 - NCT03889743RecruitingPhase 4
Steroid treatment to help prevent asthma after a first wheezing illness
This trial studies whether an early steroid treatment can lower the chance that children will go on to develop asthma after their first severe “wheezing” episode caused by a rhinovirus (a common cold virus). If you qualify, the goal is to prevent future asthma rather than just treat the current episode.
TurkuAges 3 months–1.9 years - NCT06827236RecruitingPhase 1/Phase 2
Testing a new combination treatment for advanced breast cancer
This study tests two experimental drugs, BNT323 and BNT327, together in people with advanced breast cancer. The goal is to find the best dose and see if the combination is safe and helpful.
Beverly Hills, CaliforniaAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,556 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.